Loading organizations...
§ Private Profile · New York City, NY, USA
Healthcare AI venture studio developing and launching AI companies focused on administrative automation for health systems.
Ascertain is a New York City-based healthcare artificial intelligence venture studio and joint venture that develops and launches AI companies focused on clinical and administrative workflows. Operating with a team of approximately 30 employees, the platform incubates startups that provide automation technology for health systems, payers, and pharmacies to streamline complex administrative processes like referral management, compliance, and claims. The organization was initially capitalized with a $100 million seed commitment from its parent organizations and later secured a $10 million Series A funding round led by Deerfield Management. Its portfolio includes commercialized entities such as Optain, a noninvasive retinal imaging diagnostics company backed by $12 million in seed funding, and Caire, an AI-powered patient engagement platform. Ascertain was founded in 2022 as a strategic partnership between co-founders Northwell Health and Aegis Ventures, led by Mark Michalski.
Ascertain has raised $10.0M across 1 funding round.
Key people at Ascertain.
Ascertain was founded in 2022 by Mark Michalski (Founder and Chief Executive Officer).
Ascertain has raised $10.0M in total across 1 funding round.
Key people at Ascertain.
Ascertain Technologies is a Malaysia-based fintech software development company founded in 2008, specializing in custom SaaS solutions, process automation, payment systems, and digital strategies for banking and finance operations.[1][2][4] It serves over 200 clients across more than 12 countries, including global and regional banks, SMEs, telcos, and insurance firms, with products like DataFuze, TradeGeni, PayHub, and reg-tech tools that enhance efficiency in corporate, retail, investment, and co-operative banking.[2][4] The company emphasizes cloud-agnostic solutions, adaptive interfaces, tailor-made DevOps, AI-driven robotic process automation, and robust quality controls to deliver agile, cost-effective fintech innovations.[1][2]
Note: Search results reveal two distinct entities named Ascertain. This profile focuses on Ascertain Technologies (ascertain.tech), the established fintech firm matching the query's Malaysian context and longevity. A separate U.S.-based healthcare AI company (ascertain.com), launched around 2024 by Northwell Holdings and Aegis Ventures, automates administrative workflows for health systems but is not the primary match here.[3][5][6]
Ascertain Technologies was founded in 2008 in Kuala Lumpur, Malaysia, initially providing IT solutions, data processing, data capturing, and managed services to banks and cooperative companies in Malaysia and Singapore.[1][4] With a nimble structure enabling customized solutions, it quickly built a clientele of major global and regional banks in Southeast Asia, operating two data processing centers in Kuala Lumpur.[4] Over 17 years, it evolved from core BFSI (banking, financial services, and insurance) services to a broader fintech leader, developing ready-made products and expanding to over 1,000 implementations across 12+ countries, driven by domain expertise in addressing banking challenges.[2][7] Key pivots include embracing AI, reg-tech, and automation to meet evolving technological demands.[1]
Ascertain Technologies rides the global fintech wave by pioneering automation and digital transformation in banking, particularly in Southeast Asia where legacy systems meet rising digital demands.[1][2] Its timing aligns with post-pandemic acceleration in payments, reg-tech, and AI adoption amid regulatory pressures and market dynamism, enabling banks to optimize ROI, scale effortlessly, and thrive competitively.[2] Market forces like increasing cross-border operations (12+ countries) and SME digitization favor its adaptive, cost-effective solutions, reducing manual errors in areas like cheque clearing and lending.[2][4] It influences the ecosystem by empowering regional players—global banks, telcos, insurers—with future-proof tools, fostering innovation in underserved markets like co-operative banking.[1][7]
Ascertain Technologies is poised for expanded global reach, leveraging its 17+ years of BFSI expertise to deepen AI integration and reg-tech offerings amid rising demand for compliant, automated finance tools.[1][2] Trends like AI-driven personalization, real-time payments, and stricter data regulations will shape its growth, potentially boosting implementations beyond 1,000 through partnerships in emerging markets.[2][4] Its influence may evolve from regional specialist to broader fintech enabler, maximizing ROI for clients navigating economic volatility—solidifying its role in shaping finance's future, just as it has since 2008.[1]
Ascertain was founded in 2022 by Mark Michalski (Founder and Chief Executive Officer).
Ascertain has raised $10.0M in total across 1 funding round.
Ascertain's investors include Deerfield Management, .406 Ventures.
Ascertain has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series A in April 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 9, 2023 | Optain | $12.0M Seed | Ascertain | — |
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 1, 2025 | $10M Series A | Deerfield Management | .406 Ventures | Announced |
